What is Luye Pharma Group Operating Cash Flow per Share?
Luye Pharma Group's operating cash flow per share for the
six
months ended in Dec. 2023 was HK$0.26.
Luye Pharma Group's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.47.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Luye Pharma Group was -11.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 6.80% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -1.00% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -1.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Luye Pharma Group's Operating Cash Flow per Share or its related term are showing as below:
HKSE:02186'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -44 Med: 19.2 Max: 50.6
Current: 6.8
During the past 13 years, Luye Pharma Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 50.60% per year. The lowest was -44.00% per year. And the median was 19.20% per year.
HKSE:02186's 3-Year OCF Growth Rate is ranked worse than 50.87% of 806
companies
in the Drug Manufacturers industry
Industry Median: 7.25
vs HKSE:02186: 6.80
Luye Pharma Group Operating Cash Flow per Share Historical Data
The historical data trend for Luye Pharma Group's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Luye Pharma Group Operating Cash Flow per Share Chart
Competitive Comparison of Luye Pharma Group's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Luye Pharma Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Luye Pharma Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Luye Pharma Group's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Luye Pharma Group's Price-to-Operating-Cash-Flow falls into.
Luye Pharma Group Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Luye Pharma Group's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Luye Pharma Group Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Luye Pharma Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Luye Pharma Group (HKSE:02186) Business Description
Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on developing, producing, and selling pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company's highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for global use in Asia, Europe, and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02186 has been successfully added to your 